Evidence that sequence homologous region in LRAT-like proteins possesses anti-proliferative activity and DNA binding properties: Translational implications and mechanism of action

Carcinogenesis

Volumn 27, Issue 4, 2006, Pages 693-707

  Simmons, Denise Perry ^a   Peach, Megan L ^b   Friedman, Jonathan R ^a   Green, Michael M B ^a   Nicklaus, Marc C ^b   De Luca, Luigi M ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN E; LECITHIN RETINOL ACYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; WILD TYPE;

ACYLTRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; PEPTIDES; PROTEIN BIOSYNTHESIS; SEQUENCE HOMOLOGY; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 33645298751     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi235     Document Type: Article

References (47)

1. Myers,M.P., Stolavrov,J.P., Eng,C., Li,J., Wang,S.I., Wigler,M.H., Parsons,R. and Tonks,N.K. (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl Acad. Sci. USA, 94, 9052-9057.
2. Lind,T., Tufaro,F., McCormick,C., Lindahl,U., Lidholt,K. (1998) The Putative Tumor Suppressors EXT1 and EXT2 Are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem., 273, 26265-26268.
3. Yokoyama,F., Suzuki,N., Haruki,M., Nishi,N., Oishi,S., Fujii,N., Utani,A., Kleinman,H.K. and Nomizu,M. (2004) Cyclic peptides from the loop region of the laminin alpha 4 chain LG4 module show enhanced biological activity over linear peptides. Biochemistry, 43, 13590-13597.
4. Vidal,M. Liu,W.Q., Gril,B., Assayag,F., Puopon,M.F. and Garbay,C. (2004) Design of new anti-tumor agents interrupting deregulated signaling pathways induced by tyrosine proteins. Inhibition of protein-protein interaction involving Grb2. J. Soc. Biol., 198, 133-137.
5. Shadidi,M. and Sioud,M. (2003) Selective targeting of cancer cells using synthetic peptides. Drug Resist. Updat., 6, 363-371.
6. Haro,I. and Gomara,M.J. (2004) Design of synthetic peptide constructs for the vaccine development against viral infections. Curr. Protein. Pept. Sci., 5, 425-433.
7. Mondal,M.S., Ruiz,A., Bok,D. and Rando,R.R. (2000) Lecithin retinol acyltransferase contains cysteine residues essential for catalysis. Biochemistry, 39, 5215-5220.
8. Anantharaman,V. and Aravind,L. (2003) Evolutionary History Structural Features and Biochemical Diversity of the NipC/P60 Superfamily of Enzymes. Genome Biol., 4, R 11-R 12.
9. Ruiz,A., Kuehn,M.H., Andorf,J.L., Stone,E., Hageman,G.S. and Bok,D. (2001) Genomic organization and mutation analysis of the gene encoding lecithin retinol acyltransferase in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci., 42, 31-37.
10. Hajnal,A., Klemenz,R. and Schafer,R. (1994) Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Oncogene, 9, 479-490.
11. Bastien,J. and Rochette-Egly,C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene, 2004, 328, 1-16.
12. Guo,X., Knudsen,B.S., Peehl,D.M., Ruiz,A., Bok,D., Rando,R.R., Rhim,J.S., Nanus,D.D. and Gudas,L.J. (2002) Retinol metabolism and lecithin: Retinol acyltransferase are reduced in cultured human prostate cancer cells and tissue specimens. Cancer Res., 62, 1654-1661.
13. Guo,X., Ruiz,A., Rando,R., Bok,D. and Gudas,L. (2000) Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: Reduced expression of lecithin: retinol acyltransferase in carcinoma lines. Carcinogenesis, 21, 1925-1933.
14. Andreola,F., Giandomenico,V., Spero,R. and De Luca,L.M. (2000) Expression of a smaller lecithin: refnol acyl transferase transcript and reduced retinol esterification in MCF-7 cells. Biochem. Biophys. Res. Commun., 279, 920-924.
15. Kurlandsky,S., Duell,E., Kang,S., Voorhees,J. and Fisher,G. (1996) Autoregulation of retinoic acid biosynthesis through regulation of retinol esterification in human keratinocytes. J. Biol. Chem., 271, 15346-15352.
16. Simmons,D.P., Andreola,F. and De Luca,L.M. (2002) Human melanomas of fibroblast and epithelial morphology differ widely in their ability to synthesize retinyl esters. Carcinogenesis, 23, 1821-1830.
17. Sers,C., Emmenegger,U., Hussman,K., Bucher,K., Andres,A.C. and Schäfer,R. (1997) Growth-inhibitory activity and downregulation of the class ii tumor- suppressor gene H-rev107 in tumor cell lines and experimental tumors. J. Cell Biol., 136, 935-944.
18. Sun,S., Wan,H., Yue,P., Hong,W. and Lotan,R. (2000) Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition. J. Biol. Chem., 275, 17149-17153.
19. Aguda,B.D. and Tang,Y. (1999) The kinetic origins of the restriction point in the mammalian cell cycle. Cell Prolif., 32, 321-335.
20. Santoni-Rugiu,E., Falck,J., Mailand,N., Bartek,J. and Lucas,J. (2000) Involvement of Myc activity in a G1/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol., 20, 3497-3509
21. Clark,W.H. (1991) Tumor progression and the nature of cancer. Brit. J. Cancer., 64, 631-644.
22. Ahmedin,J., Tiwari,R.C., Murray,T., Ghafoor,A., Samuels,A., Ward,E., Feuer,E.J. and Thun,M.J. (2004) Cancer statistics, CA Cancer J. Clin., 54, 8-29.
23. Rigel,D., Friedman,R. and Kopf,A. (1996) Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5. J. Am. Acad. Dermatol., 35, 1012-1013.
24. Weber,P.J., Bader,J.E., Folkers,G. and Beck-Sickinger,A.G. (1998) A fast and inexpensive method for N-terminal fluorescein labeling of peptides. Bioorg. Med. Chem. Lett., 8, 597-600.
25. Hu,Z., Sun,Y. and Garen,A. (1999) Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proc. Natl Acad. Sci. USA, 96, 8161-8166.
26. Albrecht,M., Tosatto,S.C.E., Lengauer,T. and Valle,G. (2003) Simple consensus procedures are effective and sufficient in secondary structure prediction. Protein Engg, 16, 459-462.
27. Jorgensen,W.L., Maxwell,D.S. and Tirado-Rives,J. (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc., 118, 11225-11235.
28. Still,W.C., Tempczyk,A., Hawley,R.C. and Hendrickson,T. (1990) Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc., 112, 6127-6129.
29. Wimmel A, Wiedenmann,B. and Rosewicz,S. (2003) Autocrine growth inhbition by transforming growth factor beta-1(TGFbeta-1) in human neuroendocrine tumor cells. Gut, 52, 1308-1316.
30. Reeves,R., Edberg,D. and Li,Y. (2001) Architectural transcription factor HMGI (Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell Biol., 21, 575-594.
31. Balmer,J. and Blomhoff,R. (2002) Gene expression regulation by retinoic acid. J. Lipid Res., 43, 1773-1808.
32. Toulouse,A. (2000) RARβ involvement in enhancement of lung tumor cell immunogenecity revealed by array analysis. FASEB J., 14, 1224-1232.
33. Harwell,R.M., Porter,D.C., Danes,C. and Keyomarsi,K. (2000) Processing of cyclin E differs between normal and tumor breast cells. Cancer Res., 60, 481-489.
34. Bannister,A. and Kouzarides,T. (1992) Basic peptides enhance protein/DNA interaction in vitro. Nucleic Acids Res., 20, 3523.
35. Spanjaard,R.A., Sugawara,A., Ikeda,M. and Chin,W.W. (1995) Evidence that retinoid receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor beta gene in S91 melanoma cells. J. Biol. Chem., 270, 17429-17436.
36. McKenna,N. and O'Malley,B. (2001) Nuclear receptors, coregulators, ligands, and selective receptor modulators: Making sense of the patchwork quilt. Ann. NY Acad. Sci., 949, 3-5.
37. McKenna,N. and O'Malley,B. (2002) Minireview: Nuclear receptor coactivators - an update. Endocrinol., 143, 2461-2465.
38. Ellenberger,T.E., Brandl,C.J., Struhl,K. and Harrison,S.C. (1992) The GCN4 basic leucine zipper DNA as a dimmer of uninterrupted alpha helices: Crystal structure of the protein-DNA complex. Cell, 71, 1223-1237.
39. Hsieh,J.-C, Whitfield,G.K., Jurutka,P.W., Haussler,C.A., Thatcher,M.L., Thompson,P.D., Dang,H.T.L., Galligan,M.A., Oza,A.K. and Haussler,M.R. (2003) Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid responsive elelment. Endocrinol., 144, 5065-5080.
40. Rastinejad,F., Wagner,T., Zhao,Q. and Khorasanizadeh,S. (2000) Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J., 19, 1045-1054.
41. Jahng,W.J., Xue,L. and Rando,R.R. (2003) Lecithin retinol acyltransferase is a founder member of a novel family of enzymes. Biochemistry, 42, 12805-12812.
42. Sherr,C.J. and Roberts,J.M. (2004) Living with or without cyclins and cyclin-dependent kinases. Genes and Dev., 18, 2699-2711.
43. Matsumoto,Y. and Maller,J.L. (2004) A centrosomal localization signal in cyclin E required for cdk2-independent S phase entry. Science, 5697, 885-888.
44. Laing,J.H.E., Wilson,G.D. and Martindale,C.A. (2003) Proliferation rates in human malignant melanoma: relationship to clinicopathological features and outcome. Melanoma Res., 13, 271-277.
45. Heyman,R.A., Mangelsdorf D.J., Dyck,J.A., Stein,R.B., Eichele,G.I; Evans,R.M. and Thaller,C. (1992) 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68, 397-406.
46. Deucher,A., Nagpal,S., Chandraratna,R.A., Sepio,D., Robinson,N.A., Dashti,S.R. and Eckert,R.L. (2000) The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int. J. Oncol., 17, 1195-1203.
47. Buckle,A.M. and Fersht,A.R. (1994) Subsite binding in an Rnase: structure of a barnase-tetranucleotide complex at 1.76-Å resolution. Biochem., 33, 1644-1653.